Company intelligence / Profile preview

LiviWell

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

LiviWell is a longevity-focused wellness company that provides science-backed supplements and health solutions aimed at extending human healthspan. The company specializes in nutraceuticals such as NMN (Nicotinamide Mononucleotide), Resveratrol, and Spermidine, which are designed to support cellular health, metabolic function, and DNA repair. LiviWell's business model focuses on making longevity science accessible to consumers through high-quality, third-party tested products. By targeting key biological pathways associated with aging, such as NAD+ levels and sirtuin activation, the company aims to optimize long-term health and vitality.

Therapeutic areas: NeurologyOtherMetabolic Disorders
Modalities: Small moleculeNutraceuticals
Industry: Food & Nutrition

Beyond the preview

Go deeper on LiviWell.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LiviWell.

Explore the full profile